NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade
- Resource Type
- Article
- Source
- In
Toxicology and Applied Pharmacology April 2024 485 - Subject
- Language
- ISSN
- 0041-008X